CAPTRUST FINANCIAL ADVISORS - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 106 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$48,634
-54.3%
44,618
-4.0%
0.00%
Q2 2023$106,460
-5.8%
46,4890.0%0.00%
Q1 2023$112,96846,489
+4648800.0%
0.00%
Q4 2021$010.0%0.00%
Q2 2021$010.0%0.00%
Q1 2021$010.00%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$14,779,000100.00%
Artal Group S.A. 71,178,364$243,430,0005.23%
BVF INC/IL 10,963,000$37,493,0001.48%
Integral Health Asset Management, LLC 300,000$1,026,0000.30%
NEA Management Company, LLC 2,382,286$8,147,0000.22%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$122,0000.13%
PINNACLE ASSOCIATES LTD 1,852,382$6,335,0000.13%
XTX MARKETS LLC 13,242$45,0000.09%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 828,192$2,832,0000.06%
WINTON GROUP Ltd 192,890$660,0000.05%
View complete list of LEXICON PHARMACEUTICALS INC shareholders